SLC2A5 and colorectal carcinoma: To explore the expression of SLC2A5 in CRC patients, we performed qRT-PCR and western blotting analysis and found that mRNA and protein levels of SLC2A5 were significantly increased in tumours compared to paired normal tissues (Fig. 1a, b).